,Set,NGenes,Direction,PValue,FDR
1,WP_ZINC_HOMEOSTASIS,23,Down,8.76151462705466e-05,0.0429241321930621
2,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.000104438277842,0.0429241321930621
3,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.000989982232114859,0.271255131599471
4,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.00395513770218309,0.80249548034981
5,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.00518357247916596,0.80249548034981
6,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.00585763124342927,0.80249548034981
7,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.0136653828896947,0.994328688628018
8,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,2,Down,0.0137625214235123,0.994328688628018
9,WP_MACROPHAGE_MARKERS,8,Down,0.0153118336227417,0.994328688628018
10,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.0169069245213345,0.994328688628018
11,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.0171593437029345,0.994328688628018
12,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.0214594573423208,0.994328688628018
13,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.024268970710434,0.994328688628018
14,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.0242974758859371,0.994328688628018
15,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.0245561289246839,0.994328688628018
16,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.0246170142130611,0.994328688628018
17,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.0258233142547625,0.994328688628018
18,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.0258551012316411,0.994328688628018
19,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.0266229137700764,0.994328688628018
20,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Up,0.0303019275400941,0.994328688628018
21,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.0334979149282404,0.994328688628018
22,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,3,Up,0.0355312265740636,0.994328688628018
23,WP_PEPTIDE_GPCRS,11,Down,0.0355359896989969,0.994328688628018
24,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,12,Up,0.0389058251691836,0.994328688628018
25,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.0390431823102787,0.994328688628018
26,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.0390474369783069,0.994328688628018
27,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.0396385577428623,0.994328688628018
28,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0398085205777953,0.994328688628018
29,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Down,0.0416627831443354,0.994328688628018
30,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.0469256091302556,0.994328688628018
31,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.047173265738158,0.994328688628018
32,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.0477521060517773,0.994328688628018
33,WP_VITAMIN_B12_DISORDERS,9,Up,0.0494963276870368,0.994328688628018
34,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.049877287661018,0.994328688628018
35,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Up,0.0499265738967403,0.994328688628018
36,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.0513076046135391,0.994328688628018
37,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.0534932095116212,0.994328688628018
38,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.0566722663950735,0.994328688628018
39,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Up,0.0583706542608251,0.994328688628018
40,WP_AEROBIC_GLYCOLYSIS,9,Up,0.0588680428448917,0.994328688628018
41,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Up,0.0588680428448917,0.994328688628018
42,WP_SILDENAFIL_TREATMENT,12,Down,0.0646580914272961,0.994328688628018
43,WP_FRAGILE_X_SYNDROME,83,Up,0.0664941598435131,0.994328688628018
44,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.0682818631809016,0.994328688628018
45,WP_COMPLEMENT_SYSTEM,50,Down,0.0682850477283806,0.994328688628018
46,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.0686439589204081,0.994328688628018
47,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.0719297127636149,0.994328688628018
48,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.0720441326433867,0.994328688628018
49,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.0774792145241333,0.994328688628018
50,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.0780504697428643,0.994328688628018
51,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.080073340255818,0.994328688628018
52,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.0801941017610924,0.994328688628018
53,WP_MEASLES_VIRUS_INFECTION,99,Up,0.082941451850688,0.994328688628018
54,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.0852834298009804,0.994328688628018
55,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.0863284343817582,0.994328688628018
56,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.0874379167542499,0.994328688628018
57,WP_ONECARBON_METABOLISM,22,Down,0.0888033736665615,0.994328688628018
58,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.0900978962473939,0.994328688628018
59,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Down,0.0910089440414052,0.994328688628018
60,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.0910562905999072,0.994328688628018
61,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.0956273812295303,0.994328688628018
62,WP_CORI_CYCLE,11,Up,0.0962922802407492,0.994328688628018
63,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Up,0.0969131260863071,0.994328688628018
64,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.0982677986910712,0.994328688628018
65,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.100978227721932,0.994328688628018
66,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.10336660054219,0.994328688628018
67,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.104251182170237,0.994328688628018
68,WP_COPPER_HOMEOSTASIS,40,Down,0.108476335835522,0.994328688628018
69,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.113001514063033,0.994328688628018
70,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.113381696785031,0.994328688628018
71,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.116177109486525,0.994328688628018
72,WP_THERMOGENESIS,72,Up,0.117297198432476,0.994328688628018
73,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.119113904415355,0.994328688628018
74,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.120073752905464,0.994328688628018
75,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.120417196948257,0.994328688628018
76,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.120815051959654,0.994328688628018
77,WP_CREATINE_PATHWAY,2,Up,0.121363945155882,0.994328688628018
78,WP_OXIDATION_BY_CYTOCHROME_P450,14,Up,0.121433909119006,0.994328688628018
79,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.12424731817087,0.994328688628018
80,WP_TCELL_ACTIVATION_SARSCOV2,61,Down,0.125182721094661,0.994328688628018
81,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.127493269837824,0.994328688628018
82,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.128003958492368,0.994328688628018
83,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.129550425816663,0.994328688628018
84,WP_NPHP1_DELETION_SYNDROME,10,Up,0.134092494052767,0.994328688628018
85,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.134851307825313,0.994328688628018
86,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.13561461919207,0.994328688628018
87,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.136176224479761,0.994328688628018
88,WP_TAR_SYNDROME,43,Up,0.136640544368107,0.994328688628018
89,WP_NUCLEOTIDE_GPCRS,6,Up,0.138252432906519,0.994328688628018
90,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.138496895066871,0.994328688628018
91,WP_RETINOL_METABOLISM,6,Up,0.139581536623814,0.994328688628018
92,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Down,0.140648321457334,0.994328688628018
93,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.141451955649879,0.994328688628018
94,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.143680403486644,0.994328688628018
95,WP_SLEEP_REGULATION,10,Down,0.144069253273473,0.994328688628018
96,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Up,0.146285273381584,0.994328688628018
97,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.14713073705009,0.994328688628018
98,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.15056118830745,0.994328688628018
99,WP_PROTEASOME_DEGRADATION,57,Up,0.154254307969047,0.994328688628018
100,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.154778270365169,0.994328688628018
101,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Up,0.155037847627278,0.994328688628018
102,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Down,0.158011155405389,0.994328688628018
103,WP_MEVALONATE_PATHWAY,7,Down,0.1600383264047,0.994328688628018
104,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.160319587934909,0.994328688628018
105,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Down,0.160748877809343,0.994328688628018
106,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.164806577886347,0.994328688628018
107,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.165358474839888,0.994328688628018
108,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.166034429155919,0.994328688628018
109,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.166161254399121,0.994328688628018
110,WP_IL4_SIGNALING,50,Up,0.166981780235438,0.994328688628018
111,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.16871539405805,0.994328688628018
112,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Up,0.170890698738002,0.994328688628018
113,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Up,0.171287125447615,0.994328688628018
114,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.171712086401466,0.994328688628018
115,WP_NRF2ARE_REGULATION,20,Down,0.173223120980102,0.994328688628018
116,WP_LIPID_PARTICLES_COMPOSITION,4,Down,0.176878325026787,0.994328688628018
117,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.177573299845692,0.994328688628018
118,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.177625222382254,0.994328688628018
119,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.179045461468878,0.994328688628018
120,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.182389000741187,0.994328688628018
121,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.183223633429209,0.994328688628018
122,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.183455723447364,0.994328688628018
123,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.184357175476516,0.994328688628018
124,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.184398014743811,0.994328688628018
125,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.18503537468419,0.994328688628018
126,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Down,0.185037192737389,0.994328688628018
127,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.185861206630092,0.994328688628018
128,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.18611817340429,0.994328688628018
129,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.186735148427383,0.994328688628018
130,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Up,0.189660752757869,0.994328688628018
131,WP_SERINE_METABOLISM,5,Down,0.190777644111283,0.994328688628018
132,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Up,0.190864322132151,0.994328688628018
133,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.191729842283187,0.994328688628018
134,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Up,0.192516235797112,0.994328688628018
135,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.194784070674988,0.994328688628018
136,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.19537890123692,0.994328688628018
137,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.195708231299996,0.994328688628018
138,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.196439588737545,0.994328688628018
139,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.196439588737545,0.994328688628018
140,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.196866240675939,0.994328688628018
141,WP_VALPROIC_ACID_PATHWAY,9,Up,0.197378247154838,0.994328688628018
142,WP_P38_MAPK_SIGNALING,30,Up,0.197814491492847,0.994328688628018
143,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,31,Down,0.198523267292324,0.994328688628018
144,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.19990096807598,0.994328688628018
145,WP_OSTEOPONTIN_SIGNALING,11,Up,0.200341601942106,0.994328688628018
146,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.201276876076665,0.994328688628018
147,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Down,0.202061641109425,0.994328688628018
148,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.205385544806801,0.994328688628018
149,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Down,0.205501448529412,0.994328688628018
150,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.212278512022334,0.994328688628018
151,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.21228174146038,0.994328688628018
152,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.215195650090492,0.994328688628018
153,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.217582981312914,0.994328688628018
154,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.219354531694913,0.994328688628018
155,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.219576821033662,0.994328688628018
156,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.220193861161298,0.994328688628018
157,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.220315415543639,0.994328688628018
158,WP_PREIMPLANTATION_EMBRYO,21,Down,0.220433255873648,0.994328688628018
159,WP_PYRIMIDINE_METABOLISM,71,Down,0.221162074981153,0.994328688628018
160,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.221723370945822,0.994328688628018
161,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.223681507440985,0.994328688628018
162,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.225553076218525,0.994328688628018
163,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.227036095497266,0.994328688628018
164,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.230870511669474,0.994328688628018
165,WP_NEURAL_CREST_DIFFERENTIATION,34,Down,0.231311335201247,0.994328688628018
166,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.232111398056864,0.994328688628018
167,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.233585593838522,0.994328688628018
168,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,34,Up,0.233871530262602,0.994328688628018
169,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.235018632906922,0.994328688628018
170,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.235192731992891,0.994328688628018
171,WP_GPCRS_OTHER,11,Down,0.236295461920218,0.994328688628018
172,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.237204827114004,0.994328688628018
173,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.239705247526372,0.994328688628018
174,WP_MONOAMINE_GPCRS,3,Up,0.242896424443475,0.994328688628018
175,WP_CHOLESTASIS,8,Down,0.24354664008477,0.994328688628018
176,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Down,0.244729564034305,0.994328688628018
177,WP_TAMOXIFEN_METABOLISM,2,Up,0.246938740449231,0.994328688628018
178,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.249336194297761,0.994328688628018
179,WP_ARYLAMINE_METABOLISM,1,Up,0.250572701488859,0.994328688628018
180,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.250828975723761,0.994328688628018
181,WP_SYNAPTIC_VESICLE_PATHWAY,21,Up,0.251582517866007,0.994328688628018
182,WP_JOUBERT_SYNDROME,70,Up,0.252336822404238,0.994328688628018
183,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.253588307446456,0.994328688628018
184,WP_ATR_SIGNALING,10,Down,0.254495889567876,0.994328688628018
185,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.256878312256649,0.994328688628018
186,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.257923623705715,0.994328688628018
187,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Down,0.258058801787412,0.994328688628018
188,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.258404336472637,0.994328688628018
189,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.25941679952369,0.994328688628018
190,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.259820521363629,0.994328688628018
191,WP_ONCOSTATIN_M_SIGNALING,52,Down,0.261184978079408,0.994328688628018
192,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.261712489320219,0.994328688628018
193,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.262053140631436,0.994328688628018
194,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.262851690755441,0.994328688628018
195,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Down,0.263422963366475,0.994328688628018
196,WP_ALZHEIMERS_DISEASE,181,Up,0.263684645552975,0.994328688628018
197,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Up,0.263684645552975,0.994328688628018
198,WP_MTHFR_DEFICIENCY,18,Down,0.263791831148317,0.994328688628018
199,WP_KLEEFSTRA_SYNDROME,25,Up,0.26589607514683,0.994328688628018
200,WP_DRAVET_SYNDROME,11,Up,0.266911841737749,0.994328688628018
201,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.269054964965646,0.994328688628018
202,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.271660979583586,0.994328688628018
203,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.272477266467277,0.994328688628018
204,WP_BURN_WOUND_HEALING,57,Down,0.274016085206041,0.994328688628018
205,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.274327095145877,0.994328688628018
206,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.275418495894252,0.994328688628018
207,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.276773631562749,0.994328688628018
208,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.27898909464346,0.994328688628018
209,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.279375766676202,0.994328688628018
210,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.280351057515842,0.994328688628018
211,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Up,0.280436980158512,0.994328688628018
212,WP_TRANSLATION_FACTORS,49,Down,0.280619817962735,0.994328688628018
213,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.282147582687095,0.994328688628018
214,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.28470653716356,0.994328688628018
215,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.284886155777197,0.994328688628018
216,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Down,0.289499574643112,0.994328688628018
217,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.290119384703272,0.994328688628018
218,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Up,0.291029270439196,0.994328688628018
219,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.292310077578145,0.994328688628018
220,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.292570635522565,0.994328688628018
221,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.295008991789013,0.994328688628018
222,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Up,0.296274684912688,0.994328688628018
223,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.296365159666899,0.994328688628018
224,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.300458554996946,0.994328688628018
225,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.301505969910131,0.994328688628018
226,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.302114082824595,0.994328688628018
227,WP_SPHINGOLIPID_PATHWAY,19,Up,0.30311045338442,0.994328688628018
228,WP_5Q35_COPY_NUMBER_VARIATION,74,Down,0.305716847809056,0.994328688628018
229,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.306628999424065,0.994328688628018
230,WP_FOCAL_ADHESION,115,Up,0.307057979651222,0.994328688628018
231,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.307864632973359,0.994328688628018
232,WP_NEUROINFLAMMATION,10,Up,0.310319354380255,0.994328688628018
233,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Up,0.310862534191809,0.994328688628018
234,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.311677246404352,0.994328688628018
235,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.312666495623473,0.994328688628018
236,WP_WNT_SIGNALING_WP428,56,Up,0.314894876273118,0.994328688628018
237,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.316170862258135,0.994328688628018
238,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.31884968065171,0.994328688628018
239,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.32050819534311,0.994328688628018
240,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.320670680127869,0.994328688628018
241,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.323386341603406,0.994328688628018
242,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.323845714474119,0.994328688628018
243,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.323845714474119,0.994328688628018
244,WP_TP53_NETWORK,15,Down,0.325745786652582,0.994328688628018
245,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Down,0.326129293612655,0.994328688628018
246,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.326659169649411,0.994328688628018
247,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.327702713974714,0.994328688628018
248,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.328836453774512,0.994328688628018
249,WP_OPIOID_RECEPTOR_PATHWAYS,24,Up,0.329277165107154,0.994328688628018
250,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.330400762246196,0.994328688628018
251,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.333726639955175,0.994328688628018
252,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.333785886424612,0.994328688628018
253,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.334136321637478,0.994328688628018
254,WP_SMALL_LIGAND_GPCRS,7,Down,0.33439950570042,0.994328688628018
255,WP_PURINE_METABOLISM,10,Down,0.334769959834639,0.994328688628018
256,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.336510149664941,0.994328688628018
257,WP_PPARALPHA_PATHWAY,14,Down,0.33673511525875,0.994328688628018
258,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.33713676298107,0.994328688628018
259,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.337545342819985,0.994328688628018
260,WP_VITAMIN_D_METABOLISM,5,Up,0.339490823849469,0.994328688628018
261,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.339857270934781,0.994328688628018
262,WP_FOXA2_PATHWAY,9,Up,0.340515748319767,0.994328688628018
263,WP_PDGFRBETA_PATHWAY,26,Up,0.34119435735052,0.994328688628018
264,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.345031849619675,0.994328688628018
265,WP_MALE_INFERTILITY,66,Down,0.345925480376978,0.994328688628018
266,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.34683669503538,0.994328688628018
267,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.346970697949174,0.994328688628018
268,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.347633847888655,0.994328688628018
269,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.348543312865168,0.994328688628018
270,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.348936986106654,0.994328688628018
271,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Down,0.349044355148213,0.994328688628018
272,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.353718899041336,0.994328688628018
273,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.356757944219358,0.994328688628018
274,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.357818582117889,0.994328688628018
275,WP_HUNGER_AND_SATIETY,2,Up,0.358642092077179,0.994328688628018
276,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.35884971983499,0.994328688628018
277,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.358905612419061,0.994328688628018
278,WP_LEPTIN_SIGNALING,69,Up,0.360472809699734,0.994328688628018
279,WP_FERROPTOSIS,49,Down,0.363066198790593,0.994328688628018
280,WP_CYTOSINE_METHYLATION,7,Down,0.36449511356863,0.994328688628018
281,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.364761047092893,0.994328688628018
282,WP_BENZENE_METABOLISM,3,Up,0.364880483447468,0.994328688628018
283,WP_OVARIAN_INFERTILITY,21,Down,0.365686400834873,0.994328688628018
284,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.365948282073111,0.994328688628018
285,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.36705523806685,0.994328688628018
286,WP_HEME_BIOSYNTHESIS,8,Down,0.36705523806685,0.994328688628018
287,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Up,0.370124898894374,0.994328688628018
288,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.372602819789319,0.994328688628018
289,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Down,0.372930975097496,0.994328688628018
290,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.374742942492355,0.994328688628018
291,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.375076354231236,0.994328688628018
292,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.375938841017154,0.994328688628018
293,WP_IDO_METABOLIC_PATHWAY,6,Up,0.376087489048402,0.994328688628018
294,WP_ANGIOGENESIS,13,Down,0.376165948189976,0.994328688628018
295,WP_MATRIX_METALLOPROTEINASES,7,Up,0.376337490873602,0.994328688628018
296,WP_ATM_SIGNALING,33,Up,0.376820553496837,0.994328688628018
297,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.378253399098471,0.994328688628018
298,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.381236408535817,0.994328688628018
299,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.381406587462176,0.994328688628018
300,WP_ECTODERM_DIFFERENTIATION,74,Down,0.381630544027558,0.994328688628018
301,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.384977862932404,0.994328688628018
302,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.38566094110395,0.994328688628018
303,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.385773613469215,0.994328688628018
304,WP_G13_SIGNALING,29,Up,0.386473566418282,0.994328688628018
305,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Down,0.389440026018013,0.994328688628018
306,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Down,0.389440026018013,0.994328688628018
307,WP_IRINOTECAN_PATHWAY,5,Up,0.391189807427053,0.994328688628018
308,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Up,0.391897241184657,0.994328688628018
309,WP_PDGF_PATHWAY,36,Up,0.396118400267444,0.994328688628018
310,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.398308028598462,0.994328688628018
311,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.398624206408683,0.994328688628018
312,WP_TCELL_RECEPTOR_SIGNALING,71,Up,0.399365416866899,0.994328688628018
313,WP_AGERAGE_PATHWAY,53,Up,0.403253951607378,0.994328688628018
314,WP_HEPATITIS_B_INFECTION,114,Up,0.403727592329744,0.994328688628018
315,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.404228173178436,0.994328688628018
316,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.404852645233938,0.994328688628018
317,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.405040927388899,0.994328688628018
318,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.405563121269358,0.994328688628018
319,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.406541812226922,0.994328688628018
320,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.406574804250146,0.994328688628018
321,WP_METABOLIC_EPILEPTIC_DISORDERS,55,Up,0.407477229460427,0.994328688628018
322,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.409004197187091,0.994328688628018
323,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.410162968360945,0.994328688628018
324,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.413205883091593,0.994328688628018
325,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,31,Down,0.413322766175907,0.994328688628018
326,WP_TRYPTOPHAN_METABOLISM,17,Up,0.414935128607701,0.994328688628018
327,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.415590117885883,0.994328688628018
328,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Down,0.416390546434094,0.994328688628018
329,WP_PLEURAL_MESOTHELIOMA,240,Up,0.41796535516612,0.994328688628018
330,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.423914485729713,0.994328688628018
331,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.424627149621307,0.994328688628018
332,WP_GPR40_PATHWAY,8,Down,0.424991622052261,0.994328688628018
333,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.425282389449058,0.994328688628018
334,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.425547352449733,0.994328688628018
335,WP_NAD_METABOLISM,12,Up,0.425824507042654,0.994328688628018
336,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Up,0.42633391927899,0.994328688628018
337,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Down,0.426572456773582,0.994328688628018
338,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.426660724161082,0.994328688628018
339,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.429020085156069,0.994328688628018
340,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Down,0.429109076556984,0.994328688628018
341,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.429759888378687,0.994328688628018
342,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.42989983313139,0.994328688628018
343,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.430239721094862,0.994328688628018
344,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.431651613574255,0.994328688628018
345,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.432550876795914,0.994328688628018
346,WP_SPINA_BIFIDA,10,Down,0.43359141851393,0.994328688628018
347,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.434274733727068,0.994328688628018
348,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.437305141102372,0.994328688628018
349,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,10,Up,0.437995427169121,0.994328688628018
350,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.441284194580438,0.994328688628018
351,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.44202063998707,0.994328688628018
352,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,132,Down,0.443008732217518,0.994328688628018
353,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.443202943104719,0.994328688628018
354,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.443411314389045,0.994328688628018
355,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.44428637903313,0.994328688628018
356,WP_AUTOPHAGY,27,Up,0.44671014607776,0.994328688628018
357,WP_ENDOTHELIN_PATHWAYS,10,Up,0.446775854103946,0.994328688628018
358,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.447739238847542,0.994328688628018
359,WP_ADIPOGENESIS,82,Up,0.449102036977827,0.994328688628018
360,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.449171744712309,0.994328688628018
361,WP_MIRNA_BIOGENESIS,6,Up,0.450970602237085,0.994328688628018
362,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,16,Down,0.451145865698552,0.994328688628018
363,WP_ESTROGEN_SIGNALING,21,Up,0.45147012453915,0.994328688628018
364,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.454770738448648,0.994328688628018
365,WP_TNFALPHA_SIGNALING,83,Up,0.455533696925123,0.994328688628018
366,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.455932932151693,0.994328688628018
367,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.458941283687002,0.994328688628018
368,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.459875912330711,0.994328688628018
369,WP_BREAST_CANCER_PATHWAY,81,Down,0.460316154167726,0.994328688628018
370,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,59,Down,0.461089256977344,0.994328688628018
371,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,6,Up,0.462927876188546,0.994328688628018
372,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.463332516555342,0.994328688628018
373,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.463596022862428,0.994328688628018
374,WP_ID_SIGNALING,11,Up,0.464058033751052,0.994328688628018
375,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Up,0.46434902952797,0.994328688628018
376,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.464450786931457,0.994328688628018
377,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.465653184905066,0.994328688628018
378,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Down,0.46600426681119,0.994328688628018
379,WP_IRON_METABOLISM_DISORDERS,10,Down,0.468999145221114,0.994328688628018
380,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.469634999309752,0.994328688628018
381,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,20,Up,0.471289050918043,0.994328688628018
382,WP_RAC1PAK1P38MMP2_PATHWAY,49,Up,0.473822568332027,0.994328688628018
383,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.477063278114779,0.994328688628018
384,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.477524945786402,0.994328688628018
385,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.477542175473381,0.994328688628018
386,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Up,0.479739681605471,0.994328688628018
387,WP_RANKLRANK_SIGNALING,47,Up,0.483368464577188,0.994328688628018
388,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.483551888771438,0.994328688628018
389,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.483836015347998,0.994328688628018
390,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.486349525300879,0.994328688628018
391,WP_FOXP3_IN_COVID19,9,Down,0.487990398580431,0.994328688628018
392,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.489617135053692,0.994328688628018
393,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Up,0.490423227926842,0.994328688628018
394,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.491145366801395,0.994328688628018
395,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Down,0.491889126249716,0.994328688628018
396,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Up,0.493458398168941,0.994328688628018
397,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.495233846809496,0.994328688628018
398,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.495745485832233,0.994328688628018
399,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.496896892829693,0.994328688628018
400,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,40,Up,0.496935450898736,0.994328688628018
401,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Up,0.498284286807216,0.994328688628018
402,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.500733077836253,0.994328688628018
403,WP_BARDETBIEDL_SYNDROME,64,Up,0.500815283504884,0.994328688628018
404,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.500877356412983,0.994328688628018
405,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.50139648124184,0.994328688628018
406,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,9,Up,0.502718515284985,0.994328688628018
407,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.503020453324732,0.994328688628018
408,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.503544116941362,0.994328688628018
409,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Up,0.505806015798848,0.994328688628018
410,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.506080109150355,0.994328688628018
411,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Down,0.506170268027929,0.994328688628018
412,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Up,0.512207144639588,0.994328688628018
413,WP_CIRCADIAN_RHYTHM_GENES,114,Up,0.512270983877624,0.994328688628018
414,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.512386490786728,0.994328688628018
415,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.514752077740716,0.994328688628018
416,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Up,0.515843598725715,0.994328688628018
417,WP_GLIOBLASTOMA_SIGNALING,64,Up,0.51592912663026,0.994328688628018
418,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.516147582528613,0.994328688628018
419,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.5184310687744,0.994328688628018
420,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.51930432138485,0.994328688628018
421,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.52157616556622,0.994328688628018
422,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.52157616556622,0.994328688628018
423,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.523205838007206,0.994328688628018
424,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.524797434463713,0.994328688628018
425,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.525300823202426,0.994328688628018
426,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.526872537123783,0.994328688628018
427,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.528065087559703,0.994328688628018
428,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Down,0.530070531903416,0.994328688628018
429,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.531752945484304,0.994328688628018
430,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Down,0.531939496131698,0.994328688628018
431,WP_LUNG_FIBROSIS,31,Up,0.532231457581111,0.994328688628018
432,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Up,0.533579532786499,0.994328688628018
433,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Down,0.533842373749756,0.994328688628018
434,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.535319326458503,0.994328688628018
435,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.535562278871142,0.994328688628018
436,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.536315756241174,0.994328688628018
437,WP_TRANSSULFURATION_PATHWAY,8,Down,0.536356116090406,0.994328688628018
438,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,7,Down,0.537255406135538,0.994328688628018
439,WP_IL11_SIGNALING,40,Up,0.54070664012836,0.994328688628018
440,WP_WNT_SIGNALING_AND_PLURIPOTENCY,55,Up,0.544141242952326,0.994328688628018
441,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.544595759691728,0.994328688628018
442,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.545536156406873,0.994328688628018
443,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.545536156406873,0.994328688628018
444,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.54842138245871,0.994328688628018
445,WP_ALLOGRAFT_REJECTION,50,Down,0.549697466997202,0.994328688628018
446,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.551541065173118,0.994328688628018
447,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.55367809923273,0.994328688628018
448,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.55534263340768,0.994328688628018
449,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,111,Down,0.556306264745243,0.994328688628018
450,WP_METHYLATION_PATHWAYS,5,Up,0.561067989063428,0.994328688628018
451,WP_CILIOPATHIES,120,Up,0.564195341914884,0.994328688628018
452,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.564220633285464,0.994328688628018
453,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.565597574276006,0.994328688628018
454,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Up,0.566297093307249,0.994328688628018
455,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.566388856423845,0.994328688628018
456,WP_OSTEOBLAST_SIGNALING,3,Up,0.572556502695198,0.994328688628018
457,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,6,Up,0.574046573117722,0.994328688628018
458,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.574645435033291,0.994328688628018
459,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Down,0.575751231609812,0.994328688628018
460,WP_MONOAMINE_TRANSPORT,11,Up,0.575862847511395,0.994328688628018
461,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.576748477190589,0.994328688628018
462,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.578559755609761,0.994328688628018
463,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Up,0.579221401793595,0.994328688628018
464,WP_CAMKK2_PATHWAY,29,Down,0.579462536318518,0.994328688628018
465,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.579923631977776,0.994328688628018
466,WP_CCL18_SIGNALING,19,Up,0.580399992332314,0.994328688628018
467,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.580664378687238,0.994328688628018
468,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Down,0.582543636707208,0.994328688628018
469,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.584167753095724,0.994328688628018
470,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Up,0.58712077732141,0.994328688628018
471,WP_IL2_SIGNALING,36,Up,0.587160602960493,0.994328688628018
472,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Up,0.587433715339235,0.994328688628018
473,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.588873599209147,0.994328688628018
474,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.588929734475794,0.994328688628018
475,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.589901196101236,0.994328688628018
476,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,13,Up,0.59034981161195,0.994328688628018
477,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.59120484655901,0.994328688628018
478,WP_DNA_REPLICATION,34,Up,0.591806685361939,0.994328688628018
479,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.593491334691886,0.994328688628018
480,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Down,0.594874187625296,0.994328688628018
481,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.595604691844002,0.994328688628018
482,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,52,Up,0.59943804180035,0.994328688628018
483,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.599810968968201,0.994328688628018
484,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.59986443158133,0.994328688628018
485,WP_IL1_SIGNALING,52,Up,0.600599140625992,0.994328688628018
486,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.602349469207012,0.994328688628018
487,WP_BDNFTRKB_SIGNALING,26,Up,0.605105423271123,0.994328688628018
488,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.605388355202006,0.994328688628018
489,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.606345118005664,0.994328688628018
490,WP_PROLACTIN_SIGNALING,68,Up,0.609534005250568,0.994328688628018
491,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.612255878363241,0.994328688628018
492,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.613539617384573,0.994328688628018
493,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.614367203572037,0.994328688628018
494,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.617427472902496,0.994328688628018
495,WP_FOLATE_METABOLISM,36,Down,0.617559226238984,0.994328688628018
496,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.61986947543277,0.994328688628018
497,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.620680251883417,0.994328688628018
498,WP_PARKINSONS_DISEASE_PATHWAY,26,Down,0.621735953107308,0.994328688628018
499,WP_GASTRIN_SIGNALING,90,Down,0.624137466425406,0.994328688628018
500,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.626607590314164,0.994328688628018
501,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.627322779396733,0.994328688628018
502,WP_SMALL_CELL_LUNG_CANCER,67,Up,0.628388805870663,0.994328688628018
503,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Up,0.628977004486355,0.994328688628018
504,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.629134935414323,0.994328688628018
505,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.631621586161957,0.994328688628018
506,WP_HIPPO_SIGNALING_REGULATION,42,Up,0.633823516166025,0.994328688628018
507,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.636193887170882,0.994328688628018
508,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.63721116444882,0.994328688628018
509,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Up,0.638442056369713,0.994328688628018
510,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.641768066411772,0.994328688628018
511,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Down,0.644119554487966,0.994328688628018
512,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.645231701027419,0.994328688628018
513,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.645974676464659,0.994328688628018
514,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.6476625265953,0.994328688628018
515,WP_PURINERGIC_SIGNALING,14,Up,0.64813786459276,0.994328688628018
516,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.648519220357056,0.994328688628018
517,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.649027998411191,0.994328688628018
518,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.649433790123268,0.994328688628018
519,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.649631451394876,0.994328688628018
520,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.650187265688489,0.994328688628018
521,WP_BASE_EXCISION_REPAIR,29,Down,0.652826740745432,0.994328688628018
522,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.654856077278791,0.994328688628018
523,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.655414329184689,0.994328688628018
524,WP_APOPTOSIS,70,Up,0.655464646691634,0.994328688628018
525,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.656193978740181,0.994328688628018
526,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.656679290744801,0.994328688628018
527,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.656928413251658,0.994328688628018
528,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.657441877648474,0.994328688628018
529,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.657594829023302,0.994328688628018
530,WP_MAPK_SIGNALING,158,Up,0.658164576548378,0.994328688628018
531,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.658222113758044,0.994328688628018
532,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.658896676783489,0.994328688628018
533,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.661727337806489,0.994328688628018
534,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Down,0.663226190508837,0.994328688628018
535,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.665298397732465,0.994328688628018
536,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Up,0.666012554046324,0.994328688628018
537,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.666843464987492,0.994328688628018
538,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.667505680295285,0.994328688628018
539,WP_NETRINUNC5B_SIGNALING,35,Down,0.66966016802334,0.994328688628018
540,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Up,0.672076541386035,0.994328688628018
541,WP_VEGFAVEGFR2_SIGNALING,331,Up,0.67314761976402,0.994328688628018
542,WP_ENDOMETRIAL_CANCER,47,Down,0.674221365773618,0.994328688628018
543,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.677046047698118,0.994328688628018
544,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.681243090788898,0.994328688628018
545,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.687762457190656,0.994328688628018
546,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.688480350796211,0.994328688628018
547,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.688540205982518,0.994328688628018
548,WP_ENERGY_METABOLISM,41,Up,0.693555956953159,0.994328688628018
549,WP_INSULIN_SIGNALING,125,Up,0.694346966179165,0.994328688628018
550,WP_HYPERTROPHY_MODEL,13,Down,0.694983373587681,0.994328688628018
551,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,9,Down,0.695813381283048,0.994328688628018
552,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.696776534276915,0.994328688628018
553,WP_NRF2_PATHWAY,68,Down,0.696880346051835,0.994328688628018
554,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.698870889238712,0.994328688628018
555,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,17,Down,0.699025353106971,0.994328688628018
556,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.69977854559324,0.994328688628018
557,WP_NEPHROTIC_SYNDROME,28,Up,0.700513601602511,0.994328688628018
558,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Up,0.704802798278087,0.994328688628018
559,WP_EICOSANOID_SYNTHESIS,13,Down,0.709254961491964,0.994328688628018
560,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.709793038287937,0.994328688628018
561,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.711871092209802,0.994328688628018
562,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.712078574433455,0.994328688628018
563,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.712172601986059,0.994328688628018
564,WP_ASPIRIN_AND_MIRNAS,8,Down,0.712762857185881,0.994328688628018
565,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.713395108145197,0.994328688628018
566,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.714002890129894,0.994328688628018
567,WP_RAS_SIGNALING,113,Down,0.714615324211913,0.994328688628018
568,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.715811040855493,0.994328688628018
569,WP_PROSTAGLANDIN_SIGNALING,20,Up,0.718051987818979,0.994328688628018
570,WP_VITAMIN_B12_METABOLISM,23,Up,0.723077108230403,0.994328688628018
571,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.725224065991763,0.994328688628018
572,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.725591193364179,0.994328688628018
573,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,35,Down,0.726376991396568,0.994328688628018
574,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,87,Up,0.726556073396713,0.994328688628018
575,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.728184874566723,0.994328688628018
576,WP_ENDODERM_DIFFERENTIATION,80,Up,0.728897332657154,0.994328688628018
577,WP_IL17_SIGNALING,25,Up,0.729971747642563,0.994328688628018
578,WP_IL3_SIGNALING,46,Down,0.731766703218367,0.994328688628018
579,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.73679944239743,0.994328688628018
580,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.73717705664209,0.994328688628018
581,WP_STEROID_BIOSYNTHESIS,2,Up,0.738560673799299,0.994328688628018
582,WP_CHOLESTEROL_METABOLISM,48,Down,0.738835640840118,0.994328688628018
583,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.739508257085082,0.994328688628018
584,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.740151322698199,0.994328688628018
585,WP_KIT_RECEPTOR_SIGNALING,49,Up,0.740861978522859,0.994328688628018
586,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Down,0.74118513749292,0.994328688628018
587,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.742843861070688,0.994328688628018
588,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.743317456567812,0.994328688628018
589,WP_BENZOAPYRENE_METABOLISM,5,Up,0.744756541914726,0.994328688628018
590,WP_NEOVASCULARIZATION_PROCESSES,21,Down,0.744982800019049,0.994328688628018
591,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.746051835771512,0.994328688628018
592,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Down,0.749095361801634,0.994328688628018
593,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.751138309959098,0.994328688628018
594,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.752902607655549,0.994328688628018
595,WP_HIPPOYAP_SIGNALING,16,Up,0.753095392345405,0.994328688628018
596,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.756995724680996,0.994328688628018
597,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Down,0.757238650870826,0.994328688628018
598,WP_TGFB_SMAD_SIGNALING,7,Down,0.75858983781738,0.994328688628018
599,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Down,0.759120942565154,0.994328688628018
600,WP_KALLMANN_SYNDROME,10,Up,0.760304113894049,0.994328688628018
601,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.761669066411251,0.994328688628018
602,WP_HISTONE_MODIFICATIONS,35,Up,0.762294575888025,0.994328688628018
603,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.76322175803753,0.994328688628018
604,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,14,Down,0.764708884732374,0.994328688628018
605,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.766217582166165,0.994328688628018
606,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.766276189454786,0.994328688628018
607,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.766373722853691,0.994328688628018
608,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Up,0.767285564920079,0.994328688628018
609,WP_RETINOBLASTOMA_GENE_IN_CANCER,64,Up,0.768358392689915,0.994328688628018
610,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.769742045427309,0.994328688628018
611,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.772393679160121,0.994328688628018
612,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.772645546562192,0.994328688628018
613,WP_IL7_SIGNALING,22,Down,0.773498888518327,0.994328688628018
614,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.773524782177665,0.994328688628018
615,WP_AMINO_ACID_METABOLISM,57,Up,0.774619152131735,0.994328688628018
616,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.778606078007027,0.994328688628018
617,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.779341090382317,0.994328688628018
618,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,50,Up,0.780079226891462,0.994328688628018
619,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.78018166554793,0.994328688628018
620,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.780217590979212,0.994328688628018
621,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.780975962810218,0.994328688628018
622,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.781019097865325,0.994328688628018
623,WP_CILIARY_LANDSCAPE,182,Up,0.781433353613281,0.994328688628018
624,WP_ERBB_SIGNALING,65,Up,0.782535314489952,0.994328688628018
625,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Up,0.78259038319559,0.994328688628018
626,WP_SPINAL_CORD_INJURY,62,Down,0.786573693872534,0.994328688628018
627,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.787146401145178,0.994328688628018
628,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.787650282236708,0.994328688628018
629,WP_IL18_SIGNALING,184,Up,0.787851913320217,0.994328688628018
630,WP_PRION_DISEASE_PATHWAY,27,Down,0.790010671983563,0.994328688628018
631,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Down,0.792562050140794,0.994328688628018
632,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Up,0.792987419009062,0.994328688628018
633,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.794187725840475,0.994328688628018
634,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.794809685725851,0.994328688628018
635,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.795391561438867,0.994328688628018
636,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Up,0.795755637033069,0.994328688628018
637,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.795780673264864,0.994328688628018
638,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.798371322938166,0.994328688628018
639,WP_BLADDER_CANCER,27,Down,0.798750855070439,0.994328688628018
640,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.799393523605938,0.994328688628018
641,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,8,Up,0.800284384289881,0.994328688628018
642,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Down,0.800500797051792,0.994328688628018
643,WP_OSTEOCLAST_SIGNALING,9,Up,0.801079393799466,0.994328688628018
644,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.802786087378771,0.994328688628018
645,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.804251876948358,0.994328688628018
646,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Up,0.805685971378438,0.994328688628018
647,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.813071709719979,0.994328688628018
648,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Up,0.814150497462559,0.994328688628018
649,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Up,0.815205892373201,0.994328688628018
650,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.815408512859834,0.994328688628018
651,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.816851949901745,0.994328688628018
652,WP_EGFEGFR_SIGNALING,136,Up,0.817412579719151,0.994328688628018
653,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.818955592973362,0.994328688628018
654,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Down,0.820254120437741,0.994328688628018
655,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.821191069291657,0.994328688628018
656,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,81,Up,0.821465802128949,0.994328688628018
657,WP_NOTCH_SIGNALING_WP61,46,Up,0.823059508672076,0.994328688628018
658,WP_CHEMOKINE_SIGNALING,106,Down,0.823883022155603,0.994328688628018
659,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.824596534200359,0.994328688628018
660,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.824902045416333,0.994328688628018
661,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.82628522056871,0.994328688628018
662,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.826592714443491,0.994328688628018
663,WP_ACUTE_MYELOID_LEUKEMIA,53,Down,0.827005242981214,0.994328688628018
664,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.828570858466284,0.994328688628018
665,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.828842868618528,0.994328688628018
666,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.830529428208372,0.994328688628018
667,WP_KININKALLIKREIN_PATHWAY,2,Down,0.831398667713639,0.994328688628018
668,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Up,0.831871309013025,0.994328688628018
669,WP_SEROTONIN_AND_ANXIETY,5,Down,0.832989700243651,0.994328688628018
670,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.833372266493776,0.994328688628018
671,WP_IL5_SIGNALING,36,Up,0.834125811994207,0.994328688628018
672,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.83432530553421,0.994328688628018
673,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.83574534430753,0.994328688628018
674,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.836912448213041,0.994328688628018
675,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Down,0.83861221766812,0.994328688628018
676,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.83865005298243,0.994328688628018
677,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.838843773474652,0.994328688628018
678,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.838900698348299,0.994328688628018
679,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.838995692770843,0.994328688628018
680,WP_DNA_MISMATCH_REPAIR,21,Down,0.843114034815443,0.994328688628018
681,WP_IL9_SIGNALING,15,Down,0.847379895817414,0.994328688628018
682,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.849405142445154,0.994328688628018
683,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.849887715991918,0.994328688628018
684,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.850046815974794,0.994328688628018
685,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Down,0.850554365238842,0.994328688628018
686,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.852675465973114,0.994328688628018
687,WP_KREBS_CYCLE_DISORDERS,11,Up,0.852894055356271,0.994328688628018
688,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.853694070570452,0.994328688628018
689,WP_GASTRIC_CANCER_NETWORK_2,23,Up,0.85432839751566,0.994328688628018
690,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Down,0.855194212608956,0.994328688628018
691,WP_INTEGRATED_CANCER_PATHWAY,38,Up,0.856030933069171,0.994328688628018
692,WP_B_CELL_RECEPTOR_SIGNALING,82,Up,0.857792589927697,0.994328688628018
693,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Up,0.859548140910265,0.994328688628018
694,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.860095409615202,0.994328688628018
695,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,43,Up,0.863708455165292,0.994328688628018
696,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.864550932412929,0.994328688628018
697,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.864960472312362,0.994328688628018
698,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.866261002553999,0.994328688628018
699,WP_ALSTROM_SYNDROME,27,Down,0.866532684887434,0.994328688628018
700,WP_COMPLEMENT_ACTIVATION,12,Up,0.867230628462176,0.994328688628018
701,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.869319707775102,0.994328688628018
702,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.870200622836982,0.994328688628018
703,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.87075530756316,0.994328688628018
704,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.872532697148617,0.994328688628018
705,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.872827275625899,0.994328688628018
706,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.873239340889919,0.994328688628018
707,WP_CELLULAR_PROTEOSTASIS,6,Down,0.875031415908107,0.994328688628018
708,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.877848540419302,0.994328688628018
709,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.87856191233007,0.994328688628018
710,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.878974268434816,0.994328688628018
711,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Up,0.880829101799977,0.994328688628018
712,WP_VITAMIN_D_RECEPTOR_PATHWAY,79,Down,0.880952599994236,0.994328688628018
713,WP_NOTCH_SIGNALING_WP268,33,Down,0.882650088767118,0.994328688628018
714,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Up,0.883021089102453,0.994328688628018
715,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Down,0.883089991438242,0.994328688628018
716,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.883276753642804,0.994328688628018
717,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.884395203697181,0.994328688628018
718,WP_CELL_CYCLE,91,Down,0.885944141684317,0.994328688628018
719,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Down,0.886271375662117,0.994328688628018
720,WP_IL6_SIGNALING,39,Down,0.888295222264002,0.994328688628018
721,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Down,0.8901246236048,0.994328688628018
722,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Up,0.891402583721515,0.994328688628018
723,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.892498694584665,0.994328688628018
724,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.892714462557481,0.994328688628018
725,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.893753781265258,0.994328688628018
726,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Up,0.894716007597124,0.994328688628018
727,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.896076164639233,0.994328688628018
728,WP_OREXIN_RECEPTOR_PATHWAY,113,Down,0.898396178651265,0.994328688628018
729,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.898603380916034,0.994328688628018
730,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Up,0.899865911254532,0.994328688628018
731,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.901298164644436,0.994328688628018
732,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.901499903281125,0.994328688628018
733,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.901581994804178,0.994328688628018
734,WP_G_PROTEIN_SIGNALING,59,Down,0.902610823742306,0.994328688628018
735,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.907226224347153,0.994328688628018
736,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.908509155155478,0.994328688628018
737,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.911516618653161,0.994328688628018
738,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Up,0.913374951775209,0.994328688628018
739,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.914831099933562,0.994328688628018
740,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.915347463459247,0.994328688628018
741,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Up,0.916291388117777,0.994328688628018
742,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.916326705765188,0.994328688628018
743,WP_TROP2_REGULATORY_SIGNALING,41,Down,0.917310174018241,0.994328688628018
744,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.917609739178281,0.994328688628018
745,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.91818809675271,0.994328688628018
746,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.918535014497071,0.994328688628018
747,WP_MRNA_PROCESSING,124,Down,0.918764183918959,0.994328688628018
748,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.919109715357514,0.994328688628018
749,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.920372569010563,0.994328688628018
750,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.920443199301811,0.994328688628018
751,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.921386412614291,0.994328688628018
752,WP_GLUTATHIONE_METABOLISM,10,Down,0.921983821480957,0.994328688628018
753,WP_NEPHROGENESIS,4,Down,0.922958911154336,0.994328688628018
754,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.923015391872742,0.994328688628018
755,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.923087838799104,0.994328688628018
756,WP_DNA_DAMAGE_RESPONSE,56,Up,0.923655568878574,0.994328688628018
757,WP_NRXN1_DELETION_SYNDROME,2,Down,0.924379393646822,0.994328688628018
758,WP_MELANOMA,53,Up,0.926250631157839,0.994328688628018
759,WP_DOPAMINE_METABOLISM,7,Down,0.930960243507991,0.994328688628018
760,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.932933618531544,0.994328688628018
761,WP_GLUCURONIDATION,7,Up,0.93319872046374,0.994328688628018
762,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Up,0.934112393785004,0.994328688628018
763,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.934998532842842,0.994328688628018
764,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.936812926415874,0.994328688628018
765,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.937605228886275,0.994328688628018
766,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.938556833396015,0.994328688628018
767,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.938575635207849,0.994328688628018
768,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.93905568125677,0.994328688628018
769,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.939374597895904,0.994328688628018
770,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Up,0.94196019519748,0.994328688628018
771,WP_GLYOXYLATE_METABOLISM,5,Up,0.942512279254158,0.994328688628018
772,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.943429945941072,0.994328688628018
773,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.946051740860828,0.994328688628018
774,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.946921105587345,0.994328688628018
775,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.949605223603665,0.994328688628018
776,WP_PI3KAKT_SIGNALING,171,Up,0.949784468810669,0.994328688628018
777,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.950849486393462,0.994328688628018
778,WP_WNT_SIGNALING_WP363,35,Down,0.954605870609213,0.994328688628018
779,WP_NUCLEAR_RECEPTORS,20,Up,0.954707224586038,0.994328688628018
780,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.955091973688295,0.994328688628018
781,WP_IL26_SIGNALING,31,Down,0.955115839551787,0.994328688628018
782,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.955549457826322,0.994328688628018
783,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.956135364598701,0.994328688628018
784,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.957227156512975,0.994328688628018
785,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.958871959935831,0.994328688628018
786,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.959180930402371,0.994328688628018
787,WP_HEART_DEVELOPMENT,15,Up,0.959195103105935,0.994328688628018
788,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.959615127573115,0.994328688628018
789,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.96224484097412,0.994328688628018
790,WP_MAPK_CASCADE,30,Down,0.962876445728096,0.994328688628018
791,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,18,Up,0.965250727769381,0.994328688628018
792,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.965452305173332,0.994328688628018
793,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.966772914271771,0.994328688628018
794,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.96736905357026,0.994328688628018
795,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.967647453592112,0.994328688628018
796,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Down,0.967807696384035,0.994328688628018
797,WP_NUCLEAR_RECEPTORS_METAPATHWAY,172,Down,0.967983866332601,0.994328688628018
798,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Up,0.969490895114197,0.994328688628018
799,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.970541893448285,0.994328688628018
800,WP_CANCER_PATHWAYS,291,Up,0.971831936660715,0.994328688628018
801,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Up,0.973855285358595,0.994328688628018
802,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.974061278439755,0.994328688628018
803,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.97463281219858,0.994328688628018
804,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.976613391692122,0.994328688628018
805,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.978019966489208,0.994328688628018
806,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.978434933322228,0.994328688628018
807,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Down,0.978468409306219,0.994328688628018
808,WP_PPAR_SIGNALING,36,Up,0.980754833357889,0.994328688628018
809,WP_RETT_SYNDROME,29,Down,0.98201179717704,0.994328688628018
810,WP_AXON_GUIDANCE,35,Up,0.983466501627844,0.994328688628018
811,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.983614185362497,0.994328688628018
812,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.984012738076029,0.994328688628018
813,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.984959321419004,0.994328688628018
814,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Up,0.98542684830603,0.994328688628018
815,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.988547554669313,0.994328688628018
816,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.988738134712256,0.994328688628018
817,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.988877513729927,0.994328688628018
818,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.989490106201604,0.994328688628018
819,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Up,0.994029494085857,0.996634849114347
820,WP_IL19_SIGNALING,20,Up,0.994432161214576,0.996634849114347
821,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.995422397959706,0.996634849114347
822,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.999634046296682,0.999634046296682
